| scholarly article | Q13442814 |
| P50 | author | John-Paul Mutebi | Q51884712 |
| Alan D T Barrett | Q60429866 | ||
| P2093 | author name string | Miguel T Suderman | |
| Monica A McArthur | |||
| Shu-Yuan Xiao | |||
| P2860 | cites work | Phylogenetic and Evolutionary Relationships among Yellow Fever Virus Isolates in Africa | Q24289056 |
| Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. | Q27469717 | ||
| Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity | Q27469876 | ||
| Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines | Q27472841 | ||
| Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus | Q27472877 | ||
| Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus | Q27486242 | ||
| A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model | Q27486498 | ||
| The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution | Q27730234 | ||
| Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution | Q27861057 | ||
| Structures and mechanisms in flavivirus fusion | Q34070126 | ||
| The machinery for flavivirus fusion with host cell membranes | Q34331567 | ||
| Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases | Q34516458 | ||
| Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. | Q34516465 | ||
| Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. | Q34610002 | ||
| Epitope mapping of flavivirus glycoproteins. | Q38166688 | ||
| Yellow fever vaccines | Q38894469 | ||
| Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice | Q39416079 | ||
| Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes | Q39416089 | ||
| Yellow fever: a decade of reemergence | Q39431134 | ||
| Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies | Q39518371 | ||
| Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine | Q39573084 | ||
| Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil | Q39595868 | ||
| Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology | Q39607499 | ||
| Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus | Q40632363 | ||
| Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. | Q40691602 | ||
| Virulence and Pathogenesis of Yellow Fever Virus Serially Passaged in Cell Culture | Q40716136 | ||
| Attenuation of aerosolized yellow fever virus after passage in cell culture. | Q40720605 | ||
| Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses | Q40724159 | ||
| Attenuation of wild-type yellow fever virus by passage in HeLa cells | Q40757947 | ||
| Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence | Q41556305 | ||
| Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants | Q41694205 | ||
| Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence | Q41732632 | ||
| Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice | Q42982028 | ||
| Hepatitis and death following vaccination with 17D-204 yellow fever vaccine | Q43032943 | ||
| Identification of naturally occurring monoclonal antibody escape variants of louping ill virus | Q43049347 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| yellow fever | Q154874 | ||
| yellow fever virus | Q836749 | ||
| P304 | page(s) | 1462-1468 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Molecular characterization of a hamster viscerotropic strain of yellow fever virus. | |
| P478 | volume | 77 |
| Q27489724 | A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection |
| Q40480964 | A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. |
| Q57028613 | Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains |
| Q40507496 | Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants |
| Q43037233 | Characterization of the RepliVax platform for replication-defective flavivirus vaccines |
| Q39168010 | Current Assessment of Yellow Fever and Yellow Fever Vaccine |
| Q27486116 | E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence |
| Q56000614 | Exploratory re-encoding of yellow fever virus genome: new insights for the design of live-attenuated viruses |
| Q26314693 | Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention |
| Q36414210 | Genomic and phylogenetic characterization of Brazilian yellow fever virus strains |
| Q29994534 | Historical Perspectives on Flavivirus Research |
| Q41548160 | Isolation and genome characterization of a novel duck Tembusu virus with a 74 nucleotide insertion in the 3' non-translated region |
| Q51730300 | Molecular determinants of Yellow Fever Virus pathogenicity in Syrian Golden Hamsters: one mutation away from virulence. |
| Q27477548 | Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability |
| Q36093502 | Mutational analysis of the West Nile virus NS4B protein |
| Q54256710 | Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. |
| Q35613346 | Pathogenesis and pathophysiology of yellow fever |
| Q40510186 | Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus |
| Q42984516 | Viral vaccine meeting held in Barcelona, October 25-28, 2003. |
| Q57168259 | What Does the Future Hold for Yellow Fever Virus? (II) |
| Q36238729 | Yellow fever vaccine |
| Q40499099 | Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression |
| Q34118209 | Yellow fever: a reemerging threat |
Search more.